BIOGEN INC. Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOGEN INC. for March 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 14 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Sell | S | 291.55 | 9,891 | 2,883,721 | 20,705 | 30.6 K to 20.7 K (-32.33 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,873 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 1,152 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,092 | 0 | 7,546 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 663 | 0 | 1,774 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 1,105 | 0 | 2,437 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 1,678 | 0 | 9,638 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 1,352 | 0 | 1,152 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 274.76 | 1,352 | 371,476 | 30,596 | 31.9 K to 30.6 K (-4.23 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,873 | 0 | 31,948 | 29.1 K to 31.9 K (+9.88 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 274.76 | 543 | 149,195 | 29,075 | 29.6 K to 29.1 K (-1.83 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 1,152 | 0 | 29,618 | 28.5 K to 29.6 K (+4.05 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 287.63 | 847 | 243,623 | 28,466 | 29.3 K to 28.5 K (-2.89 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,092 | 0 | 29,313 | 27.2 K to 29.3 K (+7.69 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 284.75 | 312 | 88,842 | 27,221 | 27.5 K to 27.2 K (-1.13 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 663 | 0 | 27,533 | 26.9 K to 27.5 K (+2.47 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 815 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 628 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,569 | 0 | 6,828 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 398 | 0 | 1,062 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,375 | 0 | 4,960 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 662 | 0 | 1,460 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 1,103 | 0 | 6,335 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 738 | 0 | 628 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 1,841 | 0 | 8,397 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 384 | 105,508 | 10,014 | 10.4 K to 10 K (-3.69 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 815 | 0 | 10,398 | 9.6 K to 10.4 K (+8.50 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.60 | 296 | 81,282 | 9,583 | 9.9 K to 9.6 K (-3.00 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 628 | 0 | 9,879 | 9.3 K to 9.9 K (+6.79 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 739 | 203,048 | 9,251 | 10 K to 9.3 K (-7.40 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,569 | 0 | 9,990 | 8.4 K to 10 K (+18.63 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 274.76 | 727 | 199,751 | 8,421 | 9.1 K to 8.4 K (-7.95 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 284.75 | 188 | 53,533 | 9,148 | 9.3 K to 9.1 K (-2.01 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 398 | 0 | 9,336 | 8.9 K to 9.3 K (+4.45 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 287.63 | 647 | 186,097 | 8,938 | 9.6 K to 8.9 K (-6.75 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,375 | 0 | 9,585 | 8.2 K to 9.6 K (+16.75 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 121 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 321 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 163 | 0 | 596 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 76 | 0 | 208 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 128 | 0 | 284 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 131 | 0 | 759 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 143 | 0 | 121 | |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 274.76 | 3 | 824 | 4,505 | 4.5 K to 4.5 K (-0.07 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 121 | 0 | 4,508 | 4.4 K to 4.5 K (+2.76 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 274.76 | 8 | 2,198 | 4,387 | 4.4 K to 4.4 K (-0.18 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 321 | 0 | 4,395 | 4.1 K to 4.4 K (+7.88 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 287.63 | 53 | 15,244 | 4,074 | 4.1 K to 4.1 K (-1.28 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 163 | 0 | 4,127 | 4 K to 4.1 K (+4.11 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 284.75 | 25 | 7,119 | 3,964 | 4 K to 4 K (-0.63 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 76 | 0 | 3,989 | 3.9 K to 4 K (+1.94 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | M | 0.00 | 1,494 | 0 | 5,392 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | M | 0.00 | 570 | 0 | 1,522 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | J | 0.00 | 952 | 0 | 2,092 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | J | 0.00 | 1,198 | 0 | 6,886 | |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Payment of Exercise | F | 287.63 | 485 | 139,501 | 8,752 | 9.2 K to 8.8 K (-5.25 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Buy | M | 0.00 | 1,494 | 0 | 9,237 | 7.7 K to 9.2 K (+19.29 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Payment of Exercise | F | 284.75 | 253 | 72,042 | 7,743 | 8 K to 7.7 K (-3.16 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Buy | M | 0.00 | 570 | 0 | 7,996 | 7.4 K to 8 K (+7.68 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,300 | 0 | 1 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 1,174 | 0 | 0 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 1,494 | 0 | 5,392 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 728 | 0 | 1,948 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1,216 | 0 | 2,676 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1,198 | 0 | 6,886 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1,378 | 0 | 1,174 | |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 274.76 | 1,083 | 297,565 | 7,177 | 8.3 K to 7.2 K (-13.11 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 2,300 | 0 | 8,260 | 6 K to 8.3 K (+38.59 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 274.76 | 553 | 151,942 | 5,960 | 6.5 K to 6 K (-8.49 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 1,174 | 0 | 6,513 | 5.3 K to 6.5 K (+21.99 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 287.63 | 485 | 139,501 | 5,339 | 5.8 K to 5.3 K (-8.33 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 1,494 | 0 | 5,824 | 4.3 K to 5.8 K (+34.50 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 284.75 | 335 | 95,391 | 4,330 | 4.7 K to 4.3 K (-7.18 %) |
Mar 02 2017 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 728 | 0 | 4,665 | 3.9 K to 4.7 K (+18.49 %) |
Mar 01 2017 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | P | 285.39 | 1,333 | 380,425 | 1,434 | 101 to 1.4 K (+1,319.80 %) |